4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-23-049722
Director disposed of 5,377,590 shares (other)
- Director acquired 3,500,000 shares (other)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SCANGOS GEORGE A Director | 2023-09-15 | Other disposition | −3,500,000 | 33,629 | I: show line 1 in the form | ||
| SCANGOS GEORGE A Director | 2023-09-15 | Other acquisition | +1,750,000 | 1,918,489 | D: show line 2 in the form | ||
| SCANGOS GEORGE A Director | 2023-09-15 | Other acquisition | +1,750,000 | 1,750,000 | I: show line 3 in the form | ||
| SCANGOS GEORGE A Director | 2023-09-15 | Other disposition | −111,644 | 0 | I: show line 4 in the form | ||
| SCANGOS GEORGE A Director | 2023-09-15 | Other disposition | −827,151 | 0 | I: show line 5 in the form | ||
| SCANGOS GEORGE A Director | 2023-09-15 | Other disposition | −111,644 | 0 | I: show line 6 in the form | ||
| SCANGOS GEORGE A Director | 2023-09-15 | Other disposition | −827,151 | 0 | I: show line 7 in the form |
Loading xslF345X05/doc4.xml…